Article
Ferroptosis: the vulnerability within a cancer monster
15 May 2023
Abstract excerpt
Treatment-resistant cancer, such as neuroendocrine prostate cancer (NEPC), is a lethal disease with limited therapeutic options. RB1 is a tumor suppressor gene that is lost in a majority of NEPC tumors. In this issue of the JCI, Wang and colleagues examined how RB1 loss may sensitize cancer cells to ferroptosis inducers through elevation of ACSL4, a key enzyme that promotes lipid peroxidation and triggers...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
